Amvuttra Interactions
No drug interactions were found for Amvuttra (vutrisiran). However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Amvuttra (vutrisiran) is in the drug class miscellaneous metabolic agents. Amvuttra (vutrisiran) is used to treat the following conditions: Cardiomyopathy of Transthyretin-Mediated Amyloidosis, Hereditary Amyloidosis, Transthyretin-Related Amyloidosis.
Amvuttra disease interactions
There are 2 disease interactions with Amvuttra (vutrisiran) which include:
Report options
QR code containing a link to this page
More about Amvuttra (vutrisiran)
- Amvuttra consumer information
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
